Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
TMDX
$65.99
-1.68%
TMDX
· TransMedics Group, Inc.
$65.99
-1.13 (-1.68%)
At close · Oct 30
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$2.29B
Shares
34.68M
Volume · Oct 30
900.11K
Avg daily vol (3M)
835.12K
All webcasts
Earnings call · FY2026 Q2
TransMedics Group, Inc. (TMDX) Q2 2026 Earnings Call
Revenue
$189.95M
+20.7% YoY
Diluted EPS
$0.41
-55.4% YoY
Gross margin
59.6%
-1.8 pp YoY
Net income
$14.68M
-57.9% YoY
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 4, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Full-year 2026 revenue guidance, excluding PAD Aviation
full year 2026
|
$737M – $757M | — |
Quarter detail
How the reported period landed and where the business moved.
Company presentation
Slides
14 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 4, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 4, 2026 · complete as-filed document